Daito PharmaceuticalLtd Balans Gezondheid
Financiële gezondheid criteriumcontroles 5/6
Daito PharmaceuticalLtd has a total shareholder equity of ¥52.1B and total debt of ¥12.1B, which brings its debt-to-equity ratio to 23.3%. Its total assets and total liabilities are ¥81.9B and ¥29.8B respectively. Daito PharmaceuticalLtd's EBIT is ¥3.7B making its interest coverage ratio -406.9. It has cash and short-term investments of ¥4.7B.
Belangrijke informatie
23.3%
Verhouding schuld/eigen vermogen
JP¥12.14b
Schuld
| Rente dekkingsratio | -406.9x |
| Contant | JP¥4.69b |
| Aandelen | JP¥52.08b |
| Totaal verplichtingen | JP¥29.85b |
| Totaal activa | JP¥81.93b |
Recente financiële gezondheidsupdates
Geen updates
Analyse van de financiële positie
Kortlopende schulden: 4577's short term assets (¥45.8B) exceed its short term liabilities (¥18.8B).
Langlopende schulden: 4577's short term assets (¥45.8B) exceed its long term liabilities (¥11.1B).
Schuld/ eigen vermogen geschiedenis en analyse
Schuldniveau: 4577's net debt to equity ratio (14.3%) is considered satisfactory.
Schuld verminderen: 4577's debt to equity ratio has increased from 14% to 23.3% over the past 5 years.
Schuldendekking: 4577's debt is well covered by operating cash flow (42.7%).
Rentedekking: 4577 earns more interest than it pays, so coverage of interest payments is not a concern.